Patient-Derived GBM Organoid Platform Probes Radiation and Drug Responses
Inside Precision Medicine7 Oct · 23:44← Topics · 7 Oct
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Newswise7 Oct · 23:44
As it stood that day
New studies are linking cancer severity and survival to molecular changes across tumour types.
20 reports · 1 area · 7 Oct
Summary · from headlines6 points
- Leor Weinberger, PhD, earns an NIH Director’s Pioneer Award to tackle evolving cancers.
- Mitochondrial DNA is linked to tumor growth, chemotherapy-related gene activity and cancer severity.
- A cancer trial drug may work differently than scientists believed, raising concerns for clinical research.
- A scalable zebrafish platform is reported for genetic validation and discovery of breast cancer metastasis regulators.
- tRNA dosage regulates treatment resistance in prostate cancer, with a key driver identified as a possible reversal target.
- An enzyme biomarker may predict CDK4/6 inhibitor resistance in breast cancer; a nuclear enzyme mechanism could help target it.
Latest developments6 to read first
Newly uncovered enzyme mechanism could help target drug-resistant breast cancer
Medical Xpress7 Oct · 23:44Nuclear enzyme discovery unlocks new paths to combat breast cancer
News-Medical7 Oct · 23:44Science Spotlight: CDK4/6 resistance that a mutation panel can’t see
BioCentury Inc.7 Oct · 23:44Enzyme Biomarker May Predict CDK4/6 Inhibitor Resistance in Breast Cancer
Inside Precision Medicine7 Oct · 23:44Timeline 20 reports
7 Oct 202620 reports
23:009 reports
22:002 reports
21:002 reports
20:001 report
19:001 report
18:001 report
17:002 reports
16:00nothing heard
15:00nothing heard
14:001 report
13:00nothing heard
12:00nothing heard
11:001 report
← Topics · 7 OctOne topic